01Impact factor
Impact factor of Journal of Hypertension (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Journal of Hypertension published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, calculated by ScholarsColab. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Peripheral Vascular Diseasesrank 90 of 109 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of Journal of Hypertension
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Journal of Hypertension is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
Is your paper a fit for Journal of Hypertension?
Most desk rejections come from a scope mismatch. Compare your title and abstract with what this journal really publishes. Free, no sign-up, about 2 minutes.
Check my paper for this journalOr find journals that fit my paper
02Review time
Review time of Journal of Hypertension
Each paper took a different time. The green box holds the middle half of the papers and the dark line is the median; the whiskers reach the fastest 10% and the slowest 10%. Plan with the whole spread, not only the median.
Half of the research articles Journal of Hypertension published between May 2026 and Oct 2026 were accepted within 130 days of submission, and the middle half took between 84 and 190 days. This time includes peer review and any revision rounds. Papers that were rejected are not counted, because only published papers carry these dates.
In Peripheral Vascular Diseases, Journal of Hypertension ranks 26 of 35 journals by review time (1 = fastest). See the fastest-review journals in Peripheral Vascular Diseases →
Need a faster review? Journal of Hypertension takes a median of 130 days; the fastest journals in Peripheral Vascular Diseases take 45.
- Blood Pressure 45 days
- Heart and Vessels 63 days
- Hypertension Research 64 days
APC waivers and discounts for Journal of Hypertension
Wolters Kluwer (Lippincott): no general country waiver for Lippincott journals; most Medknow journals charge no APC.
03Retractions
Retractions and research integrity at Journal of Hypertension
Retractions per year
Most common reasons (a retraction can have several):
Journal of Hypertension has 8 retracted papers on record, the latest in Aug 2023. A retraction count is not a verdict on a journal: large journals publish more and journals that investigate actively retract more. The trend and the reasons tell you more than the number.
04Funders
Who funds research published in Journal of Hypertension
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
05Indexing
Indexing of Journal of Hypertension
- ISSN
- 0263-6352
- eISSN
- 1473-5598
- Publisher
- Lippincott Williams and Wilkins all its journals →
- Country
- United States
- Language
- English
- Scopus source type
- Journal
- Web of Science categories
- Peripheral Vascular Diseases
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor on this page is calculated by ScholarsColab (see how the impact factor works).
Each link opens the official record for this journal, searched by its ISSN where we have one.
06How to submit
How to submit to Journal of Hypertension
- Read the guide for authors. It sets the article types, word limit, reference style and file format that Journal of Hypertension accepts. You find it on the official website of the journal, usually under "For authors" or "Submit".
- Format to the journal's style. Check whether it wants a Word file, a LaTeX file or a PDF for the first submission, and follow its reference style; many journals accept any clear format at first and ask for their style only after acceptance.
- Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Check the fee. Journal of Hypertension is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
07Reviewer comments
Reviewer comments and rejection reasons for Journal of Hypertension
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Journal of Hypertension, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Worried about the English? Manuscript editing by editors in your subject: see the price →
Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 seconds08Same subject
Peripheral Vascular Diseases journals with a similar impact factor*
The journals next to Journal of Hypertension when the 104 journals of Peripheral Vascular Diseases in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 86 | Annals of Vascular Diseases | 0.80 | ESCI | Fully open access |
| 87 | Jornal Vascular Brasileiro | 0.80 | ESCI | Fully open access |
| 88 | Journal of Vascular and Interventional Radiology | 0.79 | SCIE | Subscription |
| 89 | Clínica e Investigación en Arteriosclerosis | 0.77 | ESCI | Subscription |
| 91 | Arterial Hypertension | 0.65 | ESCI | Fully open access |
| 92 | Arterial’naya Gipertenziya (Arterial Hypertension) | 0.62 | ESCI | Some open access |
| 93 | Research and Practice in Thrombosis and Haemostasis | 0.62 | SCIE | Fully open access |
| 94 | Stroke Vascular and Interventional Neurology | 0.58 | ESCI | Fully open access |
*Impact factor calculated by ScholarsColab (2-year citedness), not the official Clarivate value.
Is Journal of Hypertension right for your paper? Find the right journal
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 157,115 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated by ScholarsColab, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time is the median days from submission to acceptance (not every publisher publishes these dates). Always check a journal’s scope and current indexing before submitting.
09Questions
Frequently asked questions
How long is the review time of Journal of Hypertension?
Based on 110 research articles Journal of Hypertension published from May 2026 to Oct 2026, the median time from submission to acceptance was 130 days, and half of them were accepted between 84 and 190 days. After acceptance, papers appeared online after a median of 37 days. Data updated October 2026. Individual papers can take longer, especially with major revisions.
What is the impact factor of Journal of Hypertension?
Based on ScholarsColab citation data (October 2026), the 2-year impact factor of Journal of Hypertension is 0.68: papers it published in the two previous years were cited 0.68 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of Journal of Hypertension?
The h-index of Journal of Hypertension is 236 (October 2026): 236 of its papers have each been cited at least 236 times. Its i10-index is 8,805.
What is the quartile of Journal of Hypertension?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Journal of Hypertension is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is Journal of Hypertension indexed in Scopus?
Yes. Journal of Hypertension appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Journal of Hypertension an SCIE journal?
Yes. Journal of Hypertension is listed in the Science Citation Index Expanded (SCIE), according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Journal of Hypertension in Journal Citation Reports (JCR)?
Yes. Journal of Hypertension is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
Does Journal of Hypertension offer an APC waiver?
Journal of Hypertension follows the policy of Wolters Kluwer (Lippincott): no general country waiver for Lippincott journals; most Medknow journals charge no APC. No country rule: the publisher decides case by case, or has no waiver scheme. Rules verified 27 October 2026; confirm on the publisher's page.
Has Journal of Hypertension retracted papers?
Yes. 8 retracted papers are on record for Journal of Hypertension, 5 of them in the last 10 years; the most common reasons are error in data, unreliable data, unreliable results and/or conclusions. A retraction count alone is not a verdict on a journal; look at the trend and the reasons. Data updated October 2026.
Who funds research published in Journal of Hypertension?
0% of 200 recent research articles in Journal of Hypertension name a funder.
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Journal of Clinical Medicine
- Chemistry - A European Journal
- Journal of the American College of Cardiology
- Journal of Immunology
- Solid State Communications
- BMJ Open
- Journal of Animal Science
- Archiv der Pharmazie
- Frontiers in Psychology
- Journal of Allergy and Clinical Immunology
- Heliyon
- Astrophysical Journal
- Journal of Magnetism and Magnetic Materials
- Applied Surface Science
Browse all journals: indexing, impact factor and reviewer comments →